Co-Authors
This is a "connection" page, showing publications co-authored by Philippe Brouqui and Didier Raoult.
Connection Strength
8.445
-
COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
Score: 0.935
-
Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238.
Score: 0.911
-
Critical reappraisal of remdesivir investigational trials in COVID-19. New Microbes New Infect. 2020 Nov; 38:100745.
Score: 0.905
-
Remdesivir investigational trials in COVID-19: a critical reappraisal. New Microbes New Infect. 2020 Jun 07; 100707.
Score: 0.886
-
Should evidence-based medicine be considered as a truth in clinical microbiology? Int J Antimicrob Agents. 2018 02; 51(2):278-279.
Score: 0.749
-
COVID-19 Management at IHU Méditerranée Infection: A One-Year Experience. J Clin Med. 2021 Jun 29; 10(13).
Score: 0.238
-
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant. J Clin Virol. 2021 06; 139:104814.
Score: 0.234
-
Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000.
Score: 0.232
-
Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
Score: 0.230
-
Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
Score: 0.225
-
Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
Score: 0.221
-
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
Score: 0.220
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
Score: 0.219
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
Score: 0.218
-
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
Score: 0.218
-
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
Score: 0.218
-
Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
Score: 0.216
-
Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities. Int J Antimicrob Agents. 2019 Apr; 53(4):355-361.
Score: 0.199
-
Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg Infect Dis. 2009 Jul; 15(7):1105-8.
Score: 0.104
-
Prevalence of skin infections in sheltered homeless. Eur J Dermatol. 2005 Sep-Oct; 15(5):382-6.
Score: 0.080
-
Determination of the nucleotide sequences of heat shock operon groESL and the citrate synthase gene (gltA) of Anaplasma (Ehrlichia) platys for phylogenetic and diagnostic studies. Clin Diagn Lab Immunol. 2002 Sep; 9(5):1132-6.
Score: 0.065
-
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
Score: 0.059
-
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290.
Score: 0.058
-
Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21.
Score: 0.058
-
Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117.
Score: 0.057
-
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
Score: 0.057
-
Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407.
Score: 0.057
-
Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
Score: 0.056
-
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
Score: 0.056
-
SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e304-e306.
Score: 0.055
-
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
Score: 0.055
-
Prevalence of antibodies to Rickettsia conorii Ricketsia africae, Rickettsia typhi and Coxiella burnetii in Mauritania. Eur J Epidemiol. 1998 Dec; 14(8):817-8.
Score: 0.050
-
Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys. Clin Microbiol Infect. 2019 Feb; 25(2):249.e1-249.e6.
Score: 0.048
-
Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections. Clin Infect Dis. 2018 02 10; 66(5):645-650.
Score: 0.047
-
Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France. Emerg Infect Dis. 2017 11; 23(11):1894-1897.
Score: 0.046
-
From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
Score: 0.046
-
Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov; 20(11):1821-7.
Score: 0.038
-
Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30.
Score: 0.036
-
Mediterranean spotted fever in Marseille: descriptive epidemiology and the influence of climatic factors. Eur J Epidemiol. 1992 Mar; 8(2):192-7.
Score: 0.031
-
Urban outbreak of Q fever, Briancon, France, March to June 1996. Euro Surveill. 1997 Feb; 2(2):12-13.
Score: 0.011